Complete revascularization for patients with multivessel coronary artery disease and ST-segment elevation myocardial infarction after the COMPLETE trial: A meta-analysis of randomized controlled trials

Background: The recently published COMPLETE trial has demonstrated that patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease (MVD), who underwent successful percutaneous coronary intervention (PCI) of both culprit and non-culprit (vs. culprit-only) lesions had a reduced risk of major adverse cardiac events (MACE), but not of cardiovascular or total mortality. The aim of this meta-analysis was to assess the efficacy of complete revascularization on cardiovascular or total mortality reduction using available randomized controlled trials (RCTs) including the COMPLETE trial, in hemodynamically stable STEMI patients with MVD. Methods: PubMed, MEDLINE, Embase, Scopus, Google Scholar, CENTRAL and ClinicalTrials.gov databases search identified 10 RCTs of 7033 patients with STEMI and MVD which compared complete (n = 3420) vs. only culprit lesion (n = 3613) PCI for a median 27.7 months follow-up. Random effect risk ratios were used to estimate for efficacy and safety outcomes. Results: Complete revascularization reduced the risk of MACE (10.4% vs.16.6%; RR = 0.59, 95% CI: 0.47 to 0.74, p < 0.0001), CV mortality (2.87% vs. 3.72%; RR = 0.73, 95% CI: 0.56 to 0.95, p = 0.02), reinfarction (5.1% vs. 7.1%; RR = 0.67, 95% CI: 0.52 to 0.86, p = 0.002), urgent revascularization (7.92% vs.17.4%; RR = 0.47, 95% CI: 0.30 to 0.73, p < 0.001), and CV hospitalization (8.68% vs.11.4%; RR = 0.65, 95% CI: 0.44to 0.96, p = 0.03) compared with culprit only revascularization. All-cause mortality, stroke, major bleeding events, or contrast induced nephropathy were not affected by the revascularization strategy. Conclusion: The findings of this meta-analysis suggest that in patients with STEMI and MVD, complete revascularization is superior to culprit-only PCI in reducing the risk of MACE outcomes, including cardiovascular mortality, without increasing the risk of adverse safety outcomes

Fabrication of Ceramic Monoliths from Diatomaceous Earth: Effects of Calcination Temperature on Silica Phase Transformation

The raw diatomaceous earth from the vicinity of Bitola (North Macedonia) showed low bulk density (0.61–0.69 g/cm3), high-water absorption (75–81%) and porosity (66–72%). The chemical composition was determined with ICP-MS, revealing the following results for the diatomaceous earth: SiO2 (63.69 wt%), Al2O3 (11.79 wt%), Fe2O3 (5.95 wt%), MnO (0.15 wt%), TiO2 (0.65 wt%), CaO (1.51 wt%), MgO (2.24 wt%), P2O5 (0.13 wt%), K2O (1.64 wt%), Na2O (0.93 wt%), LOI (11.21 wt%). XRPD data of the examined sample of clayey diatomite mainly depicted crystalline behavior with a small presence of amorphous phase. The crystalline mineral phases mainly comprise: silica (quartz), feldspars (plagioclase), mica (muscovite), chlorites and dolomite. SEM and TEM results show cased presence of micro- and nanostructures with pores ranging from 250 to 600 nm. The clayey diatomite was sintered at three temperatures (900, 1000 and 1100ºC) for a period of 1 h. XRPD of the sintered samples at 1100ºC showed certain thermal stability and formation of new phases (mullite and tridymite) that makes the analyzed diatomaceous earth suitable for production of various types of ceramic, construction and thermal insulating materials

An Improved Synthesis of 4-Chlorocoumarin-3-sulfonyl Chloride and Its Reactions with Different Bidentate Nucleophiles to Give Pyrido[1\u27,2\u27:2,3]- and Thiazino[3\u27,2\u27:2,3]-1,2,4-Thiadiazino[6,5-c]Benzopyran-6-one 7,7-Dioxides

An improved synthetic method affording 4-chlorocoumarin-3-sulfonyl chloride (4) in very good yield (ca. 85 %) is reported. This compound was reacted with various bidentate nucleophiles such as 2-aminopyridines and 2-aminothiazoles in order to obtain substituted pyrido- and thiazino-1,2,4-thiadiazino-benzopyranone dioxides (potential anticancer and anti-HIV agents). These reactions occurred rapidly at room temperature giving yellowish precipitates, which are insoluble in common organic solvents, making the purification process challenging. Further investigation has shown that these fused heterocycles are not stable and decompose with opening of the 1,2,4-thiadiazine ring

Effect of Thermal Treatment of Clayey Diatomite at Temperature Range 800-1200°C

Trepel is the local name for a mixture of diatomaceous earth and clay minerals. It represents a greyish, soft, very light, weakly cemented, fine biogenetic sedimentary rock. The studied material is taken from the vicinity of Bitola city (Republic of Macedonia). Here, clayey diatomite was treated up to three temperature intervals (800, 1000 and 1200oC) for a period of 1 hour. The X-ray powder diffraction results indicate the presence of both an amorphous phase and the following crystalline phases: quartz, feldspars (plagioclase), mica (muscovite) and chlorites. The results of SEM analysis revealed skeletons of alga Diatomeae with nano-pores. By thermal treatment of the samples, a gradual change in color as well as higher bulk density and compressive strength was observed. The increase of the temperature, in addition, affected the mineralogical composition and increased the presence of the amorphous phase (aluminasilicate glassy phase). SEM results of the thermally investigated samples depicted morphological changes expressed by shrinkage of the pore diameters in comparison to the initial material. The major and minor constituents were established by chemical analysis revealing the following chemical composition of raw clayey diatomite: SiO2 (63.65 wt%), Al2O3 (11.76 wt%), Fe2O3 (5.93 wt%), MnO (0.13 wt%), TiO2 (0.63 wt%), CaO (1.42 wt%), MgO (2.22 wt%), P2O5 (0.11 wt%), K2O (1.63 wt%), Na2O (0.92 wt%), LOI (11.50 wt%)

Effect of Thermal Treatment of Trepel at Temperature Range 800-1200˚C

Trepel is the local name for a mixture of diatomaceous earth and clay minerals. It represents a greyish, soft, very light, weakly cemented, fine biogenetic sedimentary rock. The studied material is taken from the vicinity of Bitola city (Republic of Macedonia). Here, trepel was treated up to three temperature intervals (800, 1000 and 1200ºC) for a period of 1 hour. The X-ray powder diffraction results indicate the presence of both an amorphous phase and the following crystalline phases: quartz, feldspars (plagioclase), mica (muscovite) and chlorites. The results of SEM analysis revealed skeletons of alga Diatomeae with nano-pores. By thermal treatment of the samples, a gradual change in color as well as higher bulk density and compressive strength was observed. The increase of the temperature, in addition, affected the mineralogical composition and increased the presence of the amorphous phase (aluminasilicate glassy phase). SEM results of the thermally investigated samples depicted morphological changes expressed by shrinkage of the pore diameters in comparison to the initial material. The major and minor constituents were established by chemical analysis revealing the following chemical composition of raw trepel: SiO2 (63.65 wt%), Al2O3 (11.76 wt%), Fe2O3 (5.93 wt%), MnO (0.13 wt%), TiO2 (0.63 wt%), CaO (1.42 wt%), MgO (2.22 wt%), P2O5 (0.11 wt%), K2O (1.63 wt%), Na2O (0.92 wt%), LOI (11.50 wt%)

Hydrazinyldiene-chroman-2,4-diones in inducing growth arrest and apoptosis in breast cancer cells: Synergism with doxorubicin and correlation with physicochemical properties

This study evaluates the effects of previously synthesized hydrazinyldiene-chroman-2,4-diones on cell proliferation and apoptosis, cell cycle distribution and migration capacity of MCF-7 breast cancer cells in synergy with doxorubicin. Physicochemical properties of the synthesized compounds were correlated with their structure and activity. Significant cell viability decrease in comparison with the effect of doxorubicin alone and the reference 4-hydroxycoumarin was observed when combination treatment comprising doxorubicin and the title compounds was applied. Synergistic effect with doxorubicin was also observed in down-regulation of phospho-Thr308Akt levels, confirming reduced proliferation and increased apoptosis. Combined treatment increased the percentage of cells arrested at the G2/M stage. Additive inhibition of cell migration was also observed, pointing to the possibility of reducing the risk of metastases. With their solubility profile and log D7.4, all the synthesized compounds follow Lipinski’s rule of five for good permeability (absorption) potential

3-[2-(5-tert-Butyl-1,2-oxazol-3-yl)hydrazinylidene]chroman-2,4-dione

In the title compound, C16H15N3O4, the dihedral angle between the chromane and isoxazole rings [r.m.s. deviations = 0.042 and 0.007 Å, respectively] is 20.33 (12)°. The molecular geometry is stabilized by an intramolecular N—H...O hydrogen bond. In the crystal, N—H...O hydrogen bonds generate chains along the c-axis direction. The crystal studied was a non-morohedral twin

Potential antiproliferative effect of isoxazolo- and thiazolo coumarin derivatives on breast cancer mediated bone and lung metastases

The study highlights the current progress in the development of coumarin scaffolds for drug discovery as novel anticancer agents in metastatic breast cancer. Eight compounds, combining the coumarin core and five membered heterocycles (isoxazoles and thiazoles) in hydrazinyldiene- -chroman-2,4-diones, were characterized in terms of a potential antiproliferative effect on bone (SCP1833) and lung (SCP4175) metastatic breast cancer cell lines using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay. Cell viability was evaluated after 48 and 72 h of treatment and the 50 % inhibitory concentrations were determined. The results demonstrated dose- and time-dependent activity, with the most potent molecules having a thiazole moiety, without or with additional methyl group(s) attached to the carbon(s) at position(s) 5 and/or 4 in the thiazole ring. These molecules possessed significantly higher potency against both test cell lines compared to 4-hydroxycoumari

Potential antiproliferative effect of isoxazolo- and thiazolo coumarin derivatives on breast cancer mediated bone and lung metastases

The study highlights the current progress in the development of coumarin scaffolds for drug discovery as novel anticancer agents in metastatic breast cancer. Eight compounds, combining the coumarin core and five membered heterocycles (isoxazoles and thiazoles) in hydrazinyldiene- -chroman-2,4-diones, were characterized in terms of a potential antiproliferative effect on bone (SCP1833) and lung (SCP4175) metastatic breast cancer cell lines using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay. Cell viability was evaluated after 48 and 72 h of treatment and the 50 % inhibitory concentrations were determined. The results demonstrated dose- and time-dependent activity, with the most potent molecules having a thiazole moiety, without or with additional methyl group(s) attached to the carbon(s) at position(s) 5 and/or 4 in the thiazole ring. These molecules possessed significantly higher potency against both test cell lines compared to 4-hydroxycoumari